title: Heroin relapse requires long-term potentiation-like plasticity mediated by NMDA2b-containing receptors.
abstract: Persistent relapse to addictive drugs constitutes the most challenging problem in addiction therapy, and is linked to impaired prefrontal cortex regulation of motivated behaviors involving the nucleus accumbens. Using a rat model of heroin addiction, we show that relapse requires long-term potentiation (LTP)-like increases in synaptic strength in the prefrontal cortex projection to the nucleus accumbens. The increased synaptic strength was paralleled by dendritic spine enlargement in accumbens spiny neurons and required up-regulated surface expression of NMDA2b-containing receptors (NR2B). Accordingly, blocking NR2B before reinstating heroin-seeking prevented the induction of LTP-like changes in spine remodeling and synaptic strength, and inhibited heroin relapse. These data show that LTP-like neuroplasticity in prefrontal-accumbens synapses is initiated by NR2B stimulation and strongly contributes to heroin relapse. Moreover, the data reveal NR2B-containing NMDA receptors as a previously unexplored therapeutic target for treating heroin addiction.
authors.affiliation: Department of Neurosciences, Medical University of South Carolina, Charleston, SC 29425, USA. shenhw@musc.edu
authors.forename: Haowei
authors.initials: H
authors.lastname: Shen
authors.forename: Khaled
authors.initials: K
authors.lastname: Moussawi
authors.forename: Wenhua
authors.initials: W
authors.lastname: Zhou
authors.forename: Shigenobu
authors.initials: S
authors.lastname: Toda
authors.forename: Peter W
authors.initials: PW
authors.lastname: Kalivas
mesh_terms: D000704:Analysis of Variance; D000818:Animals; D019921:Biotinylation; D003712:Dendrites / Q000648:ultrastructure; D004594:Electrophysiology; D005108:Extinction, Psychological / Q000502:physiology; D006556:Heroin Dependence / Q000503:physiopathology*; D017774:Long-Term Potentiation / Q000502:physiology*; D018613:Microscopy, Confocal; D010880:Piperidines; D017397:Prefrontal Cortex / Q000502:physiology*; D051381:Rats; D017207:Rats, Sprague-Dawley; D016194:Receptors, N-Methyl-D-Aspartate / Q000378:metabolism*; D012008:Recurrence; D012646:Self Administration; D009435:Synaptic Transmission / Q000502:physiology*
chemical_list: C121001:NR2B NMDA receptor; D010880:Piperidines; D016194:Receptors, N-Methyl-D-Aspartate; C010739:ifenprodil
references.citation: J Neurosci. 2007 Jul 25;27(30):7921-8
references.pmid: 17652583
references.citation: Biol Psychiatry. 2007 Jan 1;61(1):65-9
references.pmid: 16712807
references.citation: J Neurosci. 2008 Mar 19;28(12):3170-7
references.pmid: 18354020
references.citation: Neuropsychopharmacology. 2006 Oct;31(10):2197-209
references.pmid: 16341024
references.citation: Neurosci Lett. 2008 Oct 17;444(1):52-5
references.pmid: 18706971
references.citation: J Neurophysiol. 2008 Oct;100(4):1936-48
references.pmid: 18667547
references.citation: Proc Natl Acad Sci U S A. 2005 Apr 26;102(17):6166-71
references.pmid: 15831587
references.citation: Neuropharmacology. 2004;47 Suppl 1:33-46
references.pmid: 15464124
references.citation: Nature. 2008 Jul 3;454(7200):118-21
references.pmid: 18500330
references.citation: J Neurosci. 2005 Jun 29;25(26):6037-46
references.pmid: 15987933
references.citation: Synapse. 2002 Dec 15;46(4):271-9
references.pmid: 12373743
references.citation: Sci STKE. 2004 Oct 19;2004(255):re16
references.pmid: 15494561
references.citation: Eur J Neurosci. 2005 Nov;22(9):2332-40
references.pmid: 16262671
references.citation: J Neurosci. 2009 Mar 4;29(9):2876-84
references.pmid: 19261883
references.citation: Nat Rev Neurosci. 2008 Nov;9(11):813-25
references.pmid: 18854855
references.citation: J Neurosci. 2003 Apr 15;23(8):3531-7
references.pmid: 12716962
references.citation: Neuron. 2004 Sep 30;44(1):5-21
references.pmid: 15450156
references.citation: J Neurosci. 2011 Jun 1;31(22):8163-74
references.pmid: 21632938
references.citation: Nat Neurosci. 2009 May;12(5):602-10
references.pmid: 19349975
references.citation: Philos Trans R Soc Lond B Biol Sci. 2008 Oct 12;363(1507):3125-35
references.pmid: 18640910
references.citation: Annu Rev Neurosci. 2006;29:565-98
references.pmid: 16776597
references.citation: Annu Rev Neurosci. 2007;30:79-97
references.pmid: 17280523
references.citation: Nat Rev Neurosci. 2009 Sep;10(9):647-58
references.pmid: 19693029
references.citation: Nat Neurosci. 2001 Mar;4(3):235-6
references.pmid: 11224537
references.citation: Neuron. 2004 Sep 30;44(1):161-79
references.pmid: 15450168
references.citation: Neuron. 2009 Jul 16;63(1):40-7
references.pmid: 19607791
references.citation: Neuropharmacology. 2009;56 Suppl 1:186-95
references.pmid: 18708077
references.citation: Nat Rev Neurosci. 2009 Aug;10(8):561-72
references.pmid: 19571793
references.citation: J Neurosci. 2008 Jun 4;28(23):6046-53
references.pmid: 18524910
references.citation: Nat Neurosci. 2009 Feb;12(2):182-9
references.pmid: 19136971
references.citation: J Neurosci. 2005 Apr 20;25(16):4040-51
references.pmid: 15843606
references.citation: Nature. 2003 Jan 2;421(6918):70-5
references.pmid: 12511956
references.citation: Trends Neurosci. 2010 Sep;33(9):391-8
references.pmid: 20655604
references.citation: Neurosci Biobehav Rev. 2010 Nov;35(2):185-211
references.pmid: 20109488
references.citation: J Neurosci. 2007 Nov 14;27(46):12655-63
references.pmid: 18003845
references.citation: Neuroscience. 2008 Jan 24;151(2):579-88
references.pmid: 18061358
references.citation: Cereb Cortex. 2006 May;16(5):730-41
references.pmid: 16120796
references.citation: Nat Rev Neurosci. 2007 Nov;8(11):844-58
references.pmid: 17948030
references.citation: J Physiol Paris. 2003 Jul-Nov;97(4-6):415-22
references.pmid: 15242653
references.citation: Nature. 2004 Aug 12;430(7001):790-3
references.pmid: 15306812